Comparative effects of adefovir and selected nucleoside inhibitors of hepatitis B virus DNA polymerase on mitochondrial DNA in liver and skeletal muscle cells.
Adefovir is a potent nucleotide analog inhibitor of hepatitis B virus (HBV) DNA polymerase. Its oral prodrug adefovir dipivoxil has been approved for the treatment of chronic HBV infection. In this study, adefovir was characterized for its in vitro effects on mitochondrial DNA (mtDNA) synthesis and compared with the nucleoside analogues lamivudine (3TC), fialuridine (FIAU), and zalcitabine (ddC). No substantial changes in mtDNA content were detected in human hepatoblastoma HepG2 cells and normal human skeletal muscle cells following a 9-day treatment with 0.3-30 microm adefovir, concentrations up to 500-fold higher than the peak serum levels in patients treated with adefovir dipivoxil. Similarly, mtDNA was unchanged in both cell types following treatment with 3TC. In contrast, 30-55% and > 90% reductions in mtDNA were observed following incubation with 30 microm FIAU and ddC, respectively. The effects of FIAU on mtDNA became more pronounced following prolonged 18-day treatment of skeletal muscle cells while the effects of other drugs remained unchanged.
Birkus
G
G
Gilead Sciences, Foster City, CA 94404, USA.
Gibbs
C S
CS
Cihlar
T
T
D000225:Adenine / Q000031:analogs & derivatives / Q000494:pharmacology*; D000998:Antiviral Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D004272:DNA, Mitochondrial / Q000096:biosynthesis / Q000187:drug effects*; D006515:Hepatitis B virus / Q000187:drug effects / Q000201:enzymology*; D019694:Hepatitis B, Chronic / Q000188:drug therapy; D018197:Hepatoblastoma / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D008930:Mitochondria, Liver / Q000187:drug effects*; D018482:Muscle, Skeletal / Q000187:drug effects* / Q000378:metabolism; D019384:Nucleic Acid Synthesis Inhibitors; D063065:Organophosphonates; D014407:Tumor Cells, Cultured
D000998:Antiviral Agents; D004272:DNA, Mitochondrial; D019384:Nucleic Acid Synthesis Inhibitors; D063065:Organophosphonates; C053001:adefovir; D000225:Adenine